Rankings
▼
Calendar
BIIB FY 2017 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
FY 2017 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$12.3B
+7.2% YoY
Gross Profit
$10.6B
86.7% margin
Operating Income
$5.3B
43.6% margin
Net Income
$2.5B
20.7% margin
EPS (Diluted)
$11.92
Cash Flow
Operating Cash Flow
$4.6B
Free Cash Flow
$3.7B
Stock-Based Comp.
$128M
Balance Sheet
Total Assets
$23.7B
Total Liabilities
$11.1B
Stockholders' Equity
$12.6B
Cash & Equivalents
$1.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12.3B
$11.4B
+7.2%
Gross Profit
$10.6B
$10.0B
+6.3%
Operating Income
$5.3B
$5.2B
+3.8%
Net Income
$2.5B
$3.7B
-31.4%
← Q4 2016
All Quarters
Q1 2017 →